NCT07036900 Effects of Flexion and Extension Type Arm Slings on Walking Kinematics and Balance in Stroke Patients
| NCT ID | NCT07036900 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ceren Bayrak |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 48 participants in total. It began in 2025-05-30 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the clinic, stroke patients are seen to use flexor or extensor type arm slings, but no study was found investigating the effects of these different types of arm slings on walking kinematics and balance. The aim of the presented study was to investigate the effects of different types of arm slings on walking kinematics and balance in stroke patients and to compare them with healthy individuals.
Eligibility Criteria
Inclusion Criteria: * Inclusion criteria for EG were: (1) stroke diagnosis, (2) age 18-80, (3) independent ambulation (Functional Ambulation Category-FAS ≥ 2), (4) Modified Ashworth Scale-MAS ≤2 for gastrocnemius and biceps muscles, (5) ability to walk 10 m independently or with assistive device, (6) physician approval for an exercise program. * Inclusion criteria for CG: (1) healthy individuals without any additional neurological or orthopaedic diseases that may affect balance and gait, (2) age 18-80, (3) physician approval for an exercise program. Exclusion Criteria: * (1) severe visual impairments, (2) cerebellar involvement, (3) upper extremity Brunnstrom stage ≤ 3, (4) cancer diagnosis, (5) presence of a neurological or orthopedic condition other than stroke, (6) inability to understand and follow commands or lack of cooperation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07036900 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07036900 currently recruiting?
Yes, NCT07036900 is actively recruiting participants. Contact the research team at cerenbayrakdortkol@gmail.com for enrollment information.
Where is the NCT07036900 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07036900 clinical trial?
NCT07036900 is sponsored by Ceren Bayrak. The trial plans to enroll 48 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.